Inhaler
Latest Novartis AG Patents:
- CD19 and CD22 chimeric antigen receptors and uses thereof
- Treatment of cancer using GFR alpha-4 chimeric antigen receptor
- Tricyclic AKR1C3 dependent KARS inhibitors
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant FC fusion proteins
- Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors
Description
Claims
The ornamental design of an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D579550
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Oct 28, 2008
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: John W. Kung
Application Number: 29/292,812
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Oct 28, 2008
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: John W. Kung
Application Number: 29/292,812
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)